Evenamide as an add-on to antipsychotics demonstrates significant efficacy in patients with schizophrenia in a potentially pivotal randomized placebo-controlled trial
Autor: | Anand, R. 1, Turolla, A. 2, Chinellato, G. 2, Giuliani, R. 2, Sansi, F. 2, Hartman, R. 3 |
---|---|
Zdroj: | In Neuroscience Applied 2024 3 Supplement 2 |
Databáze: | ScienceDirect |
Externí odkaz: |